Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$32,170,664
+$9,029,511 QoQ
Shares Held
127,844
+20.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#466
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BROWN BROTHERS HARRIMAN & CO holds $677,640,956 across 15 Drug Manufacturers - General names. ABBV ranks #4 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
275,383 | $330,302,659 | |
| 2 | JNJ |
Johnson & Johnson
|
953,567 | $242,177,410 | |
| 3 | MRK |
Merck & Co., Inc.
|
257,653 | $33,108,410 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
127,844 | $32,170,664 | |
| 5 | AMGN |
Amgen Inc
|
29,505 | $10,684,350 | |
| 6 | NVS |
Novartis AG
|
50,794 | $7,960,435 | |
| 7 | PFE |
Pfizer Inc
|
327,905 | $7,895,952 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
97,895 | $5,640,709 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,170,664 | 127,844 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $23,141,153 | 106,401 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $22,621,880 | 99,006 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $21,039,113 | 90,866 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $16,148,754 | 86,999 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $16,690,153 | 79,659 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $18,852,370 | 106,091 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $17,533,459 | 88,786 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $14,854,318 | 86,604 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $16,423,963 | 90,192 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $14,125,360 | 91,149 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $14,938,644 | 100,219 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $12,857,553 | 95,432 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $15,386,217 | 96,544 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $15,314,648 | 94,763 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $12,336,851 | 91,922 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,666,007 | 89,227 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $14,132,263 | 87,177 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,122,974 | 82,149 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,330,737 | 67,959 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,439,083 | 66,043 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $7,228,230 | 66,792 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $6,969,357 | 65,043 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,367,442 | 72,696 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,780,998 | 69,067 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,037,835 | 66,122 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||